Topic 447: Development and testing of a non-invasive cryo-device to prevent chemotherapy-induced peripheral neuropathy in hands and feet of cancer patients receiving Taxol for breast cancer.

主题 447:开发和测试非侵入性冷冻装置,以预防接受紫杉醇治疗乳腺癌的癌症患者化疗引起的手脚周围神经病变。

基本信息

  • 批准号:
    10928476
  • 负责人:
  • 金额:
    $ 39.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-11 至 2024-09-10
  • 项目状态:
    已结题

项目摘要

The objective of this proposal is to develop a prototype device capable of cooling extremities to a level sufficient for prevention of chemotherapy-induced peripheral neuropathy (CIPN). Such a product will enable healthcare providers to make available a solution to prevent the physical pain and reduction in quality of life resulting from CIPN. The following Aims will be completed: (1) design, build, and validate prototypes, and (2) conduct usability and tolerability studies in a small patient cohort undergoing chemotherapy. The end of project deliverable is a validated Medacool™ prototype device with adjustable temperature within a tolerable therapeutic range with the ability to cool to therapeutic levels for 8+ hours. Through user feedback acquired in partnership with Eminence Clinical Research, Inc., the device will demonstrate ease of use in performing all critical tasks with no critical faults. The study will further provide initial indications of tolerability as well as aid in the design of a next generation prototype amenable to in-clinic, in-transit, and in-home portability for a planned Phase II pivotal efficacy and safety study in 250 patients.
这项提议的目的是开发一种原型设备,能够将肢体降温到足以预防化疗引起的周围神经病(CIPN)的水平。这样的产品将使医疗保健提供者能够提供解决方案,以防止CIPN造成的身体疼痛和生活质量下降。将完成以下目标:(1)设计、建造和验证原型,以及(2)在接受化疗的小患者队列中进行可用性和耐受性研究。项目交付成果是经过验证的Medaco ol™原型设备,其温度在可容忍的治疗范围内可调,并能够冷却到治疗水平8小时以上。通过与Eminence临床研究公司合作获得的用户反馈,该设备将展示在执行所有关键任务时的易用性,而不会出现严重故障。这项研究将进一步提供耐受性的初步迹象,并帮助设计下一代原型,适用于计划在250名患者中进行的第二阶段关键疗效和安全性研究,该原型可在诊所内、在途中和在家中携带。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carole Spangler Vaughn其他文献

Carole Spangler Vaughn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

A human slice model to understand the role of fibrosis in children with bladder exstrophy
人体切片模型了解纤维化在膀胱外翻儿童中的作用
  • 批准号:
    MR/X030946/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.98万
  • 项目类别:
    Research Grant
Development of a comprehensive microbial immunotherapy platform with immuno-transcriptomic monitoring for treatment of bladder cancer (DOCMI-BC)
开发用于治疗膀胱癌的具有免疫转录组监测的综合微生物免疫治疗平台(DOCMI-BC)
  • 批准号:
    10087336
  • 财政年份:
    2024
  • 资助金额:
    $ 39.98万
  • 项目类别:
    Collaborative R&D
BBconnect - a people-centred, system aware design feasibility investigation that aims to define innovation opportunities, generate and evaluate viable ideas for more accessible, effective and integrated bladder and bowel healthcare services.
BBconnect - 一项以人为本、系统意识的设计可行性调查,旨在定义创新机会,生成和评估可行的想法,以提供更方便、有效和综合的膀胱和肠道医疗保健服务。
  • 批准号:
    10089501
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
    Collaborative R&D
NIMBLE - an artificial intelligence-based early warning system for bladder cancer
NIMBLE——基于人工智能的膀胱癌早期预警系统
  • 批准号:
    486937
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
    Miscellaneous Programs
Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood
雌性小鼠生命早期的膀胱炎症事件导致成年后的 LUTS
  • 批准号:
    10638866
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
  • 批准号:
    10674401
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
A Robotic System to Remove Bladder Tumors Intact: The Key to Making Lifesaving Treatment Decisions
完整切除膀胱肿瘤的机器人系统:做出救生治疗决策的关键
  • 批准号:
    10760853
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
Mechanistic-Based Treatment of Interstitial Cystitis/Bladder Pain Syndrome
间质性膀胱炎/膀胱疼痛综合征的机械治疗
  • 批准号:
    10659814
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
Investigating mechanisms of bladder cancer metastasis
研究膀胱癌转移的机制
  • 批准号:
    10718278
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
用尿液检测代替侵入性膀胱镜检查进行非肌肉侵入性膀胱癌监测
  • 批准号:
    10559724
  • 财政年份:
    2023
  • 资助金额:
    $ 39.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了